Jon Napitupulu

TCG Labs Soleil secures an additional $400 million in funding, doubling down on its unique venture-biotech hybrid model. This...

Medipharm Labs has launched a new CBN/THC nighttime inhaler in Canada, expanding its cannabinoid product portfolio beyond its existing...

Boehringer Ingelheim’s strong first-half 2025 results, with 6.3% net sales growth reaching €14.0 billion, underscore the company’s diversified portfolio...

Roche’s Half-Year Results Showcase Oncology Strength, Pipeline Progress, and Strategic Shifts Roche reported robust 7% sales growth (CER) for...

Roche’s H1 2025 results reveal robust growth driven by strong pharmaceutical sales, underscoring the company’s continued success in navigating...

Opus Genetics has forged a strategic partnership with the global RDH12 Alliance to accelerate the development of OPGX-RDH12, a...

Plus Therapeutics Secures $1.6M Advance Payment for Leptomeningeal Cancer Program, Reinforcing Targeted Radiotherapy’s Rise Plus Therapeutics has received a...

Bio Usawa Biotechnology and Servaregmp are partnering to establish advanced monoclonal antibody (mAb) manufacturing capabilities in Africa. This ambitious...

ANI Pharmaceuticals announced results from its NEW DAY clinical trial evaluating the supplemental injection needs of patients with diabetic...

Rakovina Therapeutics has announced promising preclinical results for its AI-driven KT-5000AI program, focused on developing selective ATR inhibitors for...